These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 2955237
1. Plasma concentrations of immunoreactive-atrial natriuretic polypeptide in patients on hemodialysis. Kojima S, Inoue I, Hirata Y, Kimura G, Saito F, Kawano Y, Satani M, Ito K, Omae T. Nephron; 1987; 46(1):45-8. PubMed ID: 2955237 [Abstract] [Full Text] [Related]
2. Plasma concentrations of atrial natriuretic peptide, arginine vasopressin and hormones of the renin-angiotensin system in patients with end-stage renal disease. Elias AN, Vaziri ND, Pandian MR, Kaupke J. Int J Artif Organs; 1989 Mar; 12(3):153-8. PubMed ID: 2526100 [Abstract] [Full Text] [Related]
3. Plasma atrial natriuretic peptide in patients with chronic renal failure. Chen JH, Tsai JH, Lai YH, Hwang SJ. J Formos Med Assoc; 1990 Aug; 89(8):645-50. PubMed ID: 1981224 [Abstract] [Full Text] [Related]
4. Change in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis. Wilkins MR, Wood JA, Adu D, Lote CJ, Kendall MJ, Michael J. Clin Sci (Lond); 1986 Aug; 71(2):157-60. PubMed ID: 2941209 [Abstract] [Full Text] [Related]
5. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure. Haug C, Metzele A, Steffgen J, Grünert A. Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909 [Abstract] [Full Text] [Related]
6. Renal and hemodialysis clearances of endogenous natriuretic peptide. A clinical and experimental study. Deray G, Maistre G, Cacoub P, Barthelemy C, Eurin J, Carayon A, Masson F, Martinez F, Baumelou A, Legrand JC. Nephron; 1990 May; 54(2):148-53. PubMed ID: 2138254 [Abstract] [Full Text] [Related]
7. Detection of fluid overload by plasma concentration of human atrial natriuretic peptide (h-ANP) in patients with renal failure. Eisenhauer T, Talartschik J, Scheler F. Klin Wochenschr; 1986 May; 64 Suppl 6():68-72. PubMed ID: 2948067 [Abstract] [Full Text] [Related]
8. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease. Osajima A, Okazaki M, Kato H, Anai H, Tsuda Y, Segawa K, Tanaka H, Tamura M, Takasugi M, Nakashima Y. Am J Nephrol; 2001 May; 21(2):112-9. PubMed ID: 11359018 [Abstract] [Full Text] [Related]
9. Plasma concentration of human brain natriuretic peptide in patients on hemodialysis. Ishizaka Y, Yamamoto Y, Fukunaga T, Yokota N, Kida O, Kitamura K, Kangawa K, Minamino N, Matsuo H, Eto T. Am J Kidney Dis; 1994 Sep; 24(3):461-72. PubMed ID: 8079971 [Abstract] [Full Text] [Related]
10. Plasma levels of atrial natriuretic peptide and digoxin-like immunoreactive substances in intermittent peritoneal dialysis. Korzets Z, Pomeranz M, Shilo L, Pomeranze A, Levi A, Shenkman L, Berheim J. Adv Perit Dial; 1989 Sep; 5():20-3. PubMed ID: 2577411 [Abstract] [Full Text] [Related]
11. [Modification of atrial natriuretic peptide (ANP) and cyclic GMP by hemofiltration and hemodialysis]. Eisenhauer T, Talartschik J, Quentin E, Kreutzfeldt W, Scheler F. Klin Wochenschr; 1988 Sep 15; 66(18):940-5. PubMed ID: 2846948 [Abstract] [Full Text] [Related]
12. Intraindividual comparison of ANP, cGMP and plasma catecholamines between HD and CAPD. Plum J, Ziyaie M, Kemmer FW, Passlick-Deetjen J, Grabensee B. Adv Perit Dial; 1990 Sep 15; 6():211-9. PubMed ID: 1982811 [Abstract] [Full Text] [Related]
13. [Levels of immunoreactive atrial natriuretic peptide in the blood of children on hemodialysis therapy]. Jovanović O, Mirić-Nastić D, Popović-Rolović M, Antić-Peco A, Kostić M, Kruscić D. Srp Arh Celok Lek; 1992 Sep 15; 120(9-10):277-80. PubMed ID: 1306019 [Abstract] [Full Text] [Related]
14. Changes in molecular pattern of atrial natriuretic peptide in hemodialysis patients. Akiba T, Ando K, Marumo F. Int J Artif Organs; 1994 Nov 15; 17(11):585-90. PubMed ID: 7744518 [Abstract] [Full Text] [Related]
15. Effects of changes in intravascular volume on atrial size and plasma levels of immunoreactive atrial natriuretic peptide in uremic man. Cannella G, Albertini A, Assanelli D, Ghielmi S, Poiesi C, Gaggiotti M, Sandrini M, Visioli O, Maiorca R. Clin Nephrol; 1988 Oct 15; 30(4):187-92. PubMed ID: 2975201 [Abstract] [Full Text] [Related]
16. Delayed decrease in plasma levels of atrial natriuretic peptide during cold hemodialysis. Hegbrant J, Thysell H, Mårtensson L, Nielsen AL, Lindberg BF. Nephron; 1994 Oct 15; 68(4):427-32. PubMed ID: 7870226 [Abstract] [Full Text] [Related]
17. [Is the plasma ANP level an index of volume expansion in dialysis patients?]. Talartschik J, Eisenhauer T, Voth E, Sold G, Scheler F. Z Kardiol; 1988 Oct 15; 77 Suppl 2():72-7. PubMed ID: 2970178 [Abstract] [Full Text] [Related]
18. Plasma concentrations of natriuretic peptides in patients on hemodialysis. Takahashi M, Nagake Y, Ichikawa H, Kawabata K, Nakazono H, Hirata K, Ogura T, Makino H. Res Commun Mol Pathol Pharmacol; 1996 Apr 15; 92(1):19-30. PubMed ID: 8733825 [Abstract] [Full Text] [Related]
19. Atrial natriuretic peptide in plasma, atria, ventricles, and hypothalamus of Long-Evans and vasopressin-deficient Brattleboro rats. Ruskoaho H, Taskinen T, Pesonen A, Vuolteenaho O, Leppäluoto J, Tuomisto L. Endocrinology; 1989 May 15; 124(5):2595-603. PubMed ID: 2523304 [Abstract] [Full Text] [Related]
20. Plasma concentrations of atrial natriuretic peptide in various diseases. Nozuki M, Mouri T, Itoi K, Takahashi K, Totsune K, Saito T, Yoshinaga K. Tohoku J Exp Med; 1986 Apr 15; 148(4):439-47. PubMed ID: 2943055 [Abstract] [Full Text] [Related] Page: [Next] [New Search]